vimarsana.com

Page 221 - கார்னகி ஆஸ்தி க்கு சர்வதேச சமாதானம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indian-Americans are more liberal towards issues in US, conservative in India: Survey | India News

Nearly half of all Indian-Americans approve of PM Modi s performance: Survey

Mint Lite | Japan Covid vaccination, NRI s political attitude, Thai royal & more

Mint Lite | Japan Covid vaccination, NRI’s political attitude, Thai royal & more Japan will start coronavirus vaccinations next week, Prime Minister Yoshihide Suga said on WednesdayPremium 4 min read Share Via Read Full Story Japan will start coronavirus vaccinations next week, Prime Minister Yoshihide Suga said on Wednesday, but the country is scrambling to secure suitable syringes so that doses won’t go to waste. Japan is trying to secure enough special syringes that can extract the full six doses from each vial of the Pfizer vaccine. More commonly used syringes can only draw five doses meaning the last one needs to be discarded. The syringe problem could force the country to forgo enough Pfizer vaccine doses for up to 12 million people, local media estimated. For more updates, here’s Mint Lite.

Indian-Americans are more liberal towards issues in US, conservative in India: Survey

Why Russia s Deployment to Syria Can t Save the Su-57 Stealth Fighter

The Su-57 program remains under-funded and under-developed. Here s What You Need to Remember: In light of the difficulties the Su-57 program faces, the purported second Syria deployment likely achieved as much as the 2018 deployment did. Nothing much. The Russian air force deployed Su-57 stealth fighters to Syria a second time since first deploying them to the war-torn country in February 2018. But that doesn’t mean the twin-engine Su-57 is any closer to being ready for mass production, to say nothing of its readiness for full-scale warfare against a high-tech foe. The Russian military’s chief of the general staff Valery Gerasimov announced the deployment in mid-December 2019, according to TASS.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.